About RCE
Recce Pharmaceuticals Ltd (RCE) is an Australian late-stage clinical biotech company focused on the development and commercialisation of a new class of Synthetic Anti-infectives designed to address the urgent global health problem of antimicrobial resistant (AMR) superbugs.
Find out what a historical investment in Recce Pharmaceuticals would be worth today using our RCE stock calculator.
Market Capitalisation
$87.14M
Price-earnings ratio
-5.51
Dividend yield
-
High today
$0.30
Low today
$0.29
Open price
$0.30
52-week high
$0.73
52-week low
$0.29
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RCE
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in RCE on Stake
- Buy RCE from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
RCE related stocks